Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Quantification of Plasma Cell-Free Circulating DNA at Different Stages of Colorectal Cancer

26 Nov 2017

Abstract excerpt

Cell-free circulating DNAs (cfcDNAs) have been recognized as promising biomarkers for a number of cancers. This study aimed to quantify the cfcDNA in colorectal cancer to assess its potential value as biomarker. Quantification of baseline cfcDNA was determined as the amount of free glyceraldehyde 3-phosphate dehydrogenase (GAPDH) in plasma, using quantitative real-time polymerase chain reaction (PCR). The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Genetic factors in colorectal cancer
Share to Pancreatic and Hepatic Oncology Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29243990
DOI: 10.1080/07357907.2017.1408814

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Quantification of Plasma Cell-Free Circulating DNA at Different Stages of Colorectal CancerPMID 29243990Read ↗

Circulating tumor DNA in colorectal cancer: biology, methods and applicationsSemantic proximity Read ↗

Clinical utility of circulating tumor DNA for colorectal cancerSemantic proximity Read ↗

Circulating cell-free nucleic acids as biomarkers in colorectal cancer screening and diagnosis.Semantic proximity Read ↗

Use of Circulating Cell-Free DNA to Guide Precision Medicine in Patients with Colorectal Cancer.Semantic proximity Read ↗

Early detection and stratification of colorectal cancer using plasma cell-free DNA fragmentomic profilingSemantic proximity Read ↗

Clinical value of chip-based digital-PCR platform for the detection of circulating DNA in metastatic colorectal cancer.Semantic proximity Read ↗

Methodological, biological and clinical aspects of circulating free DNA in metastatic colorectal cancer.Semantic proximity Read ↗

Circulating free DNA in a screening program for early colorectal cancer detection.Semantic proximity Read ↗

The role of cell-free DNA in predicting colorectal cancer prognosis.Semantic proximity Read ↗

Detection and Monitoring of Cell‐Free DNA in Blood of Patients with Colorectal CancerSemantic proximity Read ↗

Assessing the Impact of Circulating Tumor DNA (ctDNA) in Patients With Colorectal Cancer: Separating Fact From FictionSemantic proximity Read ↗

Blood circulating tumor DNA for non-invasive genotyping of colon cancer patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.